top of page

Follow our posts on LinkedIn for the latest:

Our first publication on the ALaSCA platform, with a case study on T1D validating its capability to do both causal analysis and counterfactual simulation

March 18 2023

Download here.

New computational results extending the previous study to Drosophila and applying causal inference

Nov 1 2022

We are excited to launch our second  set of results in this draft paper uploaded to  

ALaSCA: a computational platform for quantifying the effect of proteins using Pearlian causal inference, with an example application in Alzheimer’s disease

The goal of this study was to demonstrate the ability of our computational platform to identify molecular drivers of neuronal aging using specialised causal inference techniques. S6K was highly ranked in the previous study and here the nearby neighbours in its protein interaction network were selected to explore ALaSCA’s (Adaptable Large-Scale Causal Analysis) ability to identify possible drivers of Alzheimer’s disease.

Initial computational results shining a spotlight on untapped aging genes

June 30 2022

At, we investigate neuronal aging in order to understand how cellular dysfunction in aging can contribute to the onset of neurodegenerative diseases. We are excited to launch our first set of results in this draft paper uploaded to  

Supervised machine learning with feature selection for prioritization of targets related to time-based cellular dysfunction in aging | bioRxiv


In this study, we propose a pipeline that integrates the plethora of publicly available genomic, transcriptomic, proteomic and morphological data of aging C. elegans with a supervised machine learning approach to prioritize aging-related genes in processes shared by aging and neurodegeneration. 


Our ranked output showed that 91% of the top 438 ranked genes consisted of known genes from the GenAge database, while the remaining genes had thus far not yet been associated with aging-related processes. These ranked genes can be translated to known human orthologs and serve as targets against neurodegenerative diseases.

Demonstration of our system's early capability

November 3 2021

conference title image.png
conference logo.jpg

Anti Microbial Resistance Case Study

bottom of page